Description
Odevixibat 400mcg
Each capsule contains Odevixibat sesquihydrate 415 mcg equivalent to Odevixibat……………… … 400mcg.
INDICATION
LuciOdevi is an ileal bile acid transporter (IBAT) inhibitor indicated for: Progressive Familial Intrahepatic Cholestasis (PFIC) * The treatment of pruritus in adult with progressive familial intrahepatic cholestasis (PFIC). Alagille Syndrome (ALGS) * The treatment of cholestatic pruritus in adult with Alagille syndrome (ALGS).
LIMITATIONS OF USE
LuciOdevi may not be effective in a subgroup of PFIC type 2 patients with specific ABCB11 variants resulting in nonfunctional or complete absence of the bile salt export pump protein.
DOSAGE AND USE
Recommended Dosage: PFIC:40 mcg/kg taken orally once daily. * If there is no improvement in pruritus after 3 months, the dosage may be increased in 40 mcg/kg increments up to 120 mcg/kg once daily, not to exceed a daily dosage of 6 mg/day. ALGS:120 mcg/kg taken orally once daily.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNINGS
Keep medicine out of reach of Children. Do not administer LuciOdevi during Pregnancy and Lactation.
Reviews
There are no reviews yet.